WALTHAM, Mass., Feb. 17, 2011 /PRNewswire/ — Alere Inc.
(NYSE:
ALR), a global leader in enabling individuals to take charge of
their health at home through the merger of rapid diagnostics and
health management, today announced its financial results for the
quarter ended December 31, 2010.
Financial results for the fourth quarter of 2010:
Net revenue of $578.5 million for the fourth quarter of 2010,
compared to $546.2 million for the fourth quarter of 2009. Product
and services revenues from our Professional Diagnostics segment
were $401.4 million in the fourth quarter of 2010 compared to
$362.0 million in the fourth quarter of 2009. Recent
professional diagnostics acquisitions contributed $43.8 million of
incremental net revenue compared to the fourth quarter of 2009.
North American influenza sales decreased to $8.9 million for the
fourth quarter of 2010, compared to $39.7 million for the fourth
quarter of 2009. Excluding the impact of the change in North
American influenza revenues, currency adjusted organic growth in
our Professional Diagnostics segment was 8.8%. This growth
rate benefited from the termination of a distribution relationship
for certain of our cardiology products in the fourth quarter of
2009, which reduced 2009 revenues by approximately $7.0 million.
Further, excluding this impact, the adjusted organic growth
rate in the Professional Diagnostics segment was 6.5%. Adjusted
gross margins were 55.3% for the quarter compared to 58.3% for the
fourth quarter of 2009. Adjusted gross margins from product
and services in our Professional Diagnostics segment increased
sequentially from 59.9% in the third quarter of 2010 to 60.1% in
the fourth quarter. Adjusted gross margins in our Health
Management segment decreased sequentially from 51.8% in the third
quarter of 2010 to 47.6% in the
‘/>”/>
